The Serbian competition authority has started a gun-jumping probe in the pharma retail sector, probing whether the acquisition of a pharmacy business through a public-private partnership (PPP) was supposed to be notified in the merger control procedure.

Read more on our competition blog.


Dr. Dragan Gajin

Dr. Dragan Gajin


  • Competition/Antitrust
  • Corporate, Commercial, M&A
  • Contract Law
  • State Aid
  • Private Enforcement

This website uses cookies to improve your experience.

Read More Accept